Antibody neutralizing human respiratory syncytial virus

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9963500
APP PUB NO 20170121394A1
SERIAL NO

15335560

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to monoclonal antibodies which have high anti-RSV neutralizing titers. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. The invention yet further provides for diagnostic, prophylactic and therapeutic methods employing the antibodies and nucleic acids of the invention, particularly as a passive immunotherapy agent in infants and the elderly.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MERCK SHARP & DOHME CORP.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Zhifeng Warrington, US 93 833
Cox, Kara S Harleysville, US 7 5
DiStefano, Daniel Harleysville, US 7 5
Su, Hua-Poo Phoenixville, US 7 5
Tang, Aimin Lansdale, US 18 357
Vora, Kalpit A Yardley, US 8 5
Zhang, Lan Chalfont, US 128 1430

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 8, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 8, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00